Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness.

MLA

Rao, Prakruti S., et al. “Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness.” Antibiotics (2079-6382), vol. 10, no. 6, June 2021, p. 739. EBSCOhost, https://doi.org/10.3390/antibiotics10060739.

APA

Rao, P. S., Moore, C. C., Mbonde, A. A., Nuwagira, E., Orikiriza, P., Nyehangane, D., Al-Shaer, M. H., Peloquin, C. A., Gratz, J., Pholwat, S., Arinaitwe, R., Boum, Y., Mwanga-Amumpaire, J., Houpt, E. R., Kagan, L., Heysell, S. K., & Muzoora, C. (2021). Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness. Antibiotics (2079-6382), 10(6), 739. https://doi.org/10.3390/antibiotics10060739

Chicago

Rao, Prakruti S., Christopher C. Moore, Amir A. Mbonde, Edwin Nuwagira, Patrick Orikiriza, Dan Nyehangane, Mohammad H. Al-Shaer, et al. 2021. “Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness.” Antibiotics (2079-6382) 10 (6): 739. doi:10.3390/antibiotics10060739.